-
SII to commence manufacturing of Sputnik COVID-19 vaccine in September
expresspharma
July 14, 2021
As per the agreement between RDIF and SII, the parties intend to produce over 300 million doses of the vaccine in India per year.
-
Get COVID-19 Vaccines to Poor Nations Instead of Making Booster Shots: WHO
drugs
July 14, 2021
COVID-19 vaccine makers such as Pfizer should focus on getting shots to poor countries instead of trying to persuade wealthy nations to give their citizens booster shots, World Health Organization (WHO) officials said at a press briefing held Monday.
-
WHO: Get COVID-19 Vaccines to Poor Nations Instead of Making Booster Shots
drugs
July 14, 2021
COVID-19 vaccine makers such as Pfizer should focus on getting shots to poor countries instead of trying to persuade wealthy nations to give their citizens booster shots, World Health Organization officials said at a press briefing held Monday.
-
NRx and Israel partner to advance Covid-19 vaccine development
pharmaceutical-technology
July 13, 2021
NRx Pharmaceuticals has entered a memorandum of understanding with the Government of Israel to licence exclusive global development, manufacturing and commercialisation rights to a Covid-19 vaccine, BriLife.
-
Study finds nasal COVID-19 vaccine blocks transmission, prevents disease in animals
expresspharma
July 13, 2021
The researchers noted that the vaccine only requires a single dose and it may be stored at normal refrigerator temperatures for up to at least three months.
-
Moderna signs supply pact with Argentina for 20 million doses of its COVID-19 vaccine
expresspharma
July 13, 2021
Moderna announced a supply agreement with the government of Argentina for 20 million doses of Moderna’s COVID-19 vaccine or its updated variant booster vaccine candidate, if authorised, to begin delivery in the first quarter of 2022.
-
FDA Adds Guillain-Barré Warning to J&J COVID-19 Vaccine
drugs
July 13, 2021
The U.S. Food and Drug Administration issued a new warning for the Johnson & Johnson COVID-19 vaccine that says the shot has been tied to Guillain-Barré syndrome.
-
Documents for Covaxin emergency use listing submitted to WHO; expect approval at earliest: Bharat Biotech
firstwordpharma
July 13, 2021
Bharat Biotech on Monday said it has submitted all documents required for the emergency use listing of its COVID-19 vaccine Covaxin to the World Health Organization (WHO), as reported by The Economic Times.
-
ReiThera Announces Preliminary Phase 2 Data from its COVID-19 Vaccine Candidate
prnewswire
July 13, 2021
ReiThera Srl today announces the preliminary safety and immunogenicity data from the Phase 2 clinical "COVITAR" trial with GRAd-COV2, its novel COVID-19 vaccine candidate.
-
SFDA approves Moderna’s Covid-19 vaccine for use in Saudi Arabia
pharmaceutical-technology
July 12, 2021
The Saudi Food and Drug Authority (SFDA) has granted approval for the registration of Moderna’s Covid-19 vaccine, mRNA-1273, in the Kingdom of Saudi Arabia.